Patient 4:
A 42-year-old active smoker with no known past medical history. 2-days
after being hospitalized for moderate COVID-19 moderate pneumonia and
after receiving hydroxychloroquine, azithromycin, enoxaparin,
methylprednisolone plus ritonavir/ lopinavir; he developed a left-sided
body weakness with facial asymmetry and slurring of speech of unknown
time of onset associated with a sudden decrease in the level of
consciousness with NIHSS- 9. A CT-scan brain with perfusion and C.T.
angiography showed a large area of matched perfusion defect noted in the
right MCA territory with infarction involving the right
front-temporoparietal region and a filling defect in the distal segment
of the right common carotid artery at its bifurcation. We did not offer
thrombolysis as the time of stroke onset was unclear. He was managed
conservatively with IV heparin, then changed to antiplatelets and a
rehabilitation program for the body weakness.